Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
IM Bistervels, A Buchmüller, HMG Wiegers, FN Áinle… - The Lancet, 2022 - thelancet.com
Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
IM Bistervels, A Buchmüller, HMG Wiegers, FN Áinle… - The Lancet, 2022 - pure.au.dk
Background: Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
Highlow Investigators - The Lancet, 2022 - researchinformation.amsterdamumc …
Background: Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
I Bistervels, A Buchmüller, H Wiegers, FN Áinle… - The Lancet, 2022 - hal.science
ackground: Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
IM Bistervels, A Buchmüller, HMG Wiegers, F Ní Áinle… - The Lancet, 2022 - duo.uio.no
Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
IM Bistervels, A Buchmüller, HMG Wiegers… - Lancet (London …, 2022 - europepmc.org
Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
IM Bistervels, A Buchmüller, HMG Wiegers, FN Áinle… - Lancet, 2022 - vbn.aau.dk
BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of
maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post …
maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post …
[引用][C] Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow …
IM Bistervels, A Buchmüller, HMG Wiegers, F Ni Ainle… - 2022 - repository.ubn.ru.nl
BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of
maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post …
maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post …
Intermediate-dose Versus Low-dose Low–molecular-weight Heparin in Pregnant and Postpartum Women With a History of Venous Thromboembolism (Highleow …
IM Bistervels, A Buchmüller… - Obstetric Anesthesia …, 2023 - ingentaconnect.com
(Lancet. 2022; 400: 1777–1787) Venous thromboembolism (VTE) and subsequent major
bleeding are leading causes of maternal morbidity and mortality worldwide, and the risk for …
bleeding are leading causes of maternal morbidity and mortality worldwide, and the risk for …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
IM Bistervels, A Buchmüller, HMG Wiegers… - …, 2022 - cris.maastrichtuniversity.nl
BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of
maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post …
maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post …